Defective Activation and Regulation of Type I Interferon Immunity Is Associated With Increasing COVID-19 Severity

The authors showed that in patient cohorts with different severities of COVID-19, baseline plasma interferon α measures differed according to the immunoassay used, timing of sampling, the interferon α subtype measured, and the presence of autoantibodies.